Home Alzheimer’s Disease Anti-IL-6 Agents Suggested by SITC to Treat Patients with COVID-19

Anti-IL-6 Agents Suggested by SITC to Treat Patients with COVID-19

In an editorial, researchers from the Society for Immunotherapy of Cancer (SITC) suggested that though definitive data showing that IL-6 receptor blockade benefits patients with COVID-19 induced pneumonitis are currently lacking, an effort should be made to maximize the availability of anti-IL-6 agents on a compassionate basis to treat hospitalized critically ill patients infected with COVID-19.

Further, they suggested that considerations should be given to focus efforts on rapidly expanding the ability of clinicians and clinical investigators to access investigational anti-IL-6 agents, particularly for agents where phase I and/or phase II studies have been completed and acceptable safety was demonstrated.

“Even if the primary impact of a single dose of these drugs is to accelerate recovery and get patients off ventilator support and out of the ICU more rapidly, this could…

Continue Reading to the Source

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Cause of Alzheimer’s disease traced to mutation in common enzyme

submitted by /u/scotsman81 Continue Reading to the Source

Reflections on Living With an Incurable Illness : braincancer

(I’ve checked with the moderators to make sure this is appropriate and a good fit for this subreddit. I'm a very private person, and...

This Foramen Magnum Meningioma almost killed me 18 years ago.

submitted by /u/dkrem Continue Reading to the Source

Patients, Family & Friends, and Healthcare professionals : braincancer

I am currently a PhD student based at the Marie Curie Palliative Care Research Centre at Cardiff University. My PhD is focussed on developing...

Recent Comments